Virginia 2026 Regular Session

Virginia House Bill HB391

Introduced
1/12/26  
Refer
1/12/26  
Report Pass
1/27/26  
Engrossed
1/30/26  
Refer
2/3/26  
Report Pass
2/27/26  
Enrolled
3/10/26  
Chaptered
4/22/26  

Caption

Medical cannabis program; product labels, delivery, marijuana delivery operators.

Impact

If enacted, HB 391 would significantly modify how cannabis products are dispensed in Virginia. For instance, it limits the quantity of botanical cannabis that can be dispensed, capped at four ounces every 30 days per patient, and mandates that all products are tested and labeled according to stringent standards set by the Board. This initiative is seen as a step toward more organized and compliant cannabis distribution, aiming to protect patient safety and ensure product quality.

Summary

House Bill 391 intends to amend the existing medical cannabis program in Virginia by establishing new regulations for the labeling and delivery of cannabis products. The bill specifically addresses the operations of pharmaceutical processors and cannabis dispensing facilities, detailing the criteria for dispensing cannabis to patients, such as dosage limitations and identification verification requirements. It aims to streamline the process and ensure that patients receive safe and regulated cannabis products while enhancing the accountability of those dispensing the products.

Sentiment

The response to HB 391 has been largely supportive within the medical community, particularly from those advocating for patient access to cannabis products. Many argue that the enhancements to labeling and delivery processes will help ensure that patients can safely obtain necessary treatments. However, some concerns have been expressed regarding the potential burden of regulations on small processors and the possibility of limiting patient access if restrictions become too stringent.

Contention

Key points of contention in the discussions around HB 391 include concerns from cannabis operators regarding the feasibility of adhering to the proposed regulations, especially with specific THC content limits and the requirement for comprehensive testing before product release. Additionally, some stakeholders worry that the new delivery restrictions could hinder patient access, particularly for those living in rural areas. As the bill continues through the legislative process, these debates are likely to shape its final form.

Companion Bills

No companion bills found.

Previously Filed As

VA HB1989

Medical cannabis program; changes requirements for product labels, dispensing cannabis products.

VA SB970

Cannabis control; establishes framework for creating retail market, penalties.

VA HB2485

Cannabis control; establishes framework for creating retail market, penalties.

VA HB2775

Hemp product; clarifies definition.

VA SB1376

Virginia Consumer Protection Act; food labeling.

VA SB1054

Virginia Cannabis Control Authority; draft regulations governing cannabis, report.

VA SB1395

Illegal sale of cannabis; retail tobacco & hemp products, possession by person under 21yrs. of age.

VA SB1442

Public Safety & Homeland Security & HHR, Secretaries of; combat sale of illicit cannabis products.

VA HB2366

Public Safety & Homeland Security & HHR, Secretaries of; combat sale of illicit cannabis products.

VA HB228

Virginia Consumer Protection Act; recycling information on products.

Similar Bills

VA HB1989

Medical cannabis program; changes requirements for product labels, dispensing cannabis products.

AR HB1620

To Amend The Law Concerning Pharmacy Benefits Managers; And To Regulate Processing And Payment Of Pharmacy Claims.

VA SB543

Marijuana and hemp products; enforcement.

UT SB0045

Kratom Adjustments

VA SB542

Cannabis control; establishes framework for creation of retail marijuana market, penalties, report.

VA HB642

Cannabis control; establishes framework for creation of retail marijuana market, penalties, report.